CatalystCorporate

PFIZER TOPS ESTIMATES, HIKES LOW END OF REVENUE GUIDANCE ON STRENGTH OF ELIQUIS, OTHER DRUGS - CNBC

Earnings beat and guidance hike on non-Covid strength signal corporate momentum.

What changed

Earnings beat and guidance hike on non-Covid strength signal corporate momentum.

Why it matters

Earnings beat and guidance hike on non-Covid strength signal corporate momentum. — impact context not separately stored; see What changed.

Sources